Nasal universal vaccine boosts innate immunity to shield mice from multiple respiratory pathogens
TL;DR Summary
A Stanford-led study describes an intranasal “universal vaccine” that activates the innate immune system to provide at least three months of protection in mice against SARS-CoV-2, other coronaviruses, and bacteria causing respiratory infections, while also dampening allergic responses. If safe and effective in humans, it could become a winter-wide first line of defense against diverse respiratory diseases.
Topics:health#innate-immunity#mucosal-vaccination#respiratory-allergies#sars-cov-2#science#universal-vaccine
- ‘Universal vaccine’ protects mice against multiple pathogens Nature
- Single vaccine could protect against all coughs, colds and flus, researchers say BBC
- One vaccine may provide broad protection against many respiratory infections and allergens Stanford Medicine
- Universal vaccine for cold, flu, COVID and allergies moves a step closer, scientists say Sky News
- Scientists develop universal vaccine to protect against allergies, cold and flu The Independent
Reading Insights
Total Reads
1
Unique Readers
10
Time Saved
6 min
vs 7 min read
Condensed
95%
1,234 → 57 words
Want the full story? Read the original article
Read on Nature